AAAAAA

   
Results: 1-14 |
Results: 14
Synthesis and biological evaluation of 2-(3 '-(1H-tetrazol-5-yl) bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 receptor antagonist
Authors: Costantino, G Maltoni, K Marinozzi, M Camaioni, E Prezeau, L Pin, JP Pellicciari, R
Citation: G. Costantino et al., Synthesis and biological evaluation of 2-(3 '-(1H-tetrazol-5-yl) bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 receptor antagonist, BIO MED CH, 9(2), 2001, pp. 221-227
Adenosine deaminase: Functional implications and different classes of inhibitors
Authors: Cristalli, G Costanzi, S Lambertucci, C Lupidi, G Vittori, S Volpini, R Camaioni, E
Citation: G. Cristalli et al., Adenosine deaminase: Functional implications and different classes of inhibitors, MED RES REV, 21(2), 2001, pp. 105-128
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis
Authors: Costantino, G Macchiarulo, A Camaioni, E Pellicciari, R
Citation: G. Costantino et al., Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis, J MED CHEM, 44(23), 2001, pp. 3786-3794
Use of RP-HPLC on a dynamically coated artificial membrane to predict intestinal absorption of bile acids
Authors: Natalini, B Camaioni, E Colagioia, S Pellicciari, R
Citation: B. Natalini et al., Use of RP-HPLC on a dynamically coated artificial membrane to predict intestinal absorption of bile acids, CHROMATOGR, 53, 2001, pp. S453-S455
Coupling of 2,6-dichloropurine and 2,6-dichlorodeazapurines with ribose and ribose modified sugars
Authors: Vittori, S Camaioni, E Costanzi, S Volpini, R Cristalli, G
Citation: S. Vittori et al., Coupling of 2,6-dichloropurine and 2,6-dichlorodeazapurines with ribose and ribose modified sugars, NUCLEOS NUC, 18(4-5), 1999, pp. 587-590
Synthesis and receptor affinity of polysubstituted adenosines
Authors: Vittori, S Camaioni, E Costanzi, S Volpini, R Klotz, KN Cristalli, G
Citation: S. Vittori et al., Synthesis and receptor affinity of polysubstituted adenosines, NUCLEOS NUC, 18(4-5), 1999, pp. 739-740
Structure-activity relationships of adenosine deaminase inhibitors
Authors: Vittori, S Camaioni, E Costanzi, S Volpini, R Lupidi, G Cristalli, G
Citation: S. Vittori et al., Structure-activity relationships of adenosine deaminase inhibitors, NUCLEOS NUC, 18(4-5), 1999, pp. 741-742
Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
Authors: Volpini, R Camaioni, E Costanzi, S Vittori, S Klotz, KN Cristalli, G
Citation: R. Volpini et al., Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes., NUCLEOS NUC, 18(11-12), 1999, pp. 2511-2520
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis
Authors: Jacobson, KA Hoffmann, C Kim, YC Camaioni, E Nandanan, E Jang, SY Guo, DP Ji, XD von Kugelgen, I Moro, S Ziganshin, AU Rychkov, A King, BF Brown, SG Wildman, SS Burnstock, G Boyer, JL Mohanram, A Harden, TK
Citation: Ka. Jacobson et al., Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis, PROG BRAIN, 120, 1999, pp. 119-132
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A(3) adenosine receptors
Authors: Klotz, KN Camaioni, E Volpini, R Kachler, S Vittori, S Cristalli, G
Citation: Kn. Klotz et al., 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A(3) adenosine receptors, N-S ARCH PH, 360(2), 1999, pp. 103-108
Structure-activity relationships of bisphosphate nucleotide derivatives asP2Y(1) receptor antagonists and partial agonists
Authors: Nandanan, E Camaioni, E Jang, SY Kim, YC Cristalli, G Herdewijn, P Secrist, JA Tiwari, KN Mohanram, A Harden, TK Boyer, JL Jacobson, KA
Citation: E. Nandanan et al., Structure-activity relationships of bisphosphate nucleotide derivatives asP2Y(1) receptor antagonists and partial agonists, J MED CHEM, 42(9), 1999, pp. 1625-1638
Characterization of potent ligands at human recombinant adenosine receptors
Authors: Cristalli, G Camaioni, E Costanzi, S Vittori, S Volpini, R Klotz, KN
Citation: G. Cristalli et al., Characterization of potent ligands at human recombinant adenosine receptors, DRUG DEV R, 45(3-4), 1998, pp. 176-181
Synthesis and structure-activity relationships of pyridoxal-6-arylazo-5 '-phosphate and phosphonate derivatives as P2 receptor antagonists
Authors: Kim, YC Camaioni, E Ziganshin, AU Ji, XD King, BF Wildman, SS Rychkov, A Yoburn, J Kim, H Mohanram, A Harden, T Boyer, JL Burnstock, G Jacobson, KA
Citation: Yc. Kim et al., Synthesis and structure-activity relationships of pyridoxal-6-arylazo-5 '-phosphate and phosphonate derivatives as P2 receptor antagonists, DRUG DEV R, 45(2), 1998, pp. 52-66
Synthesis of new 3 '-deoxyribonucleosides employing the acid-catalyzed fusion method
Authors: Volpini, R Camaioni, E Costanzi, S Vittori, S Cristalli, G
Citation: R. Volpini et al., Synthesis of new 3 '-deoxyribonucleosides employing the acid-catalyzed fusion method, HELV CHIM A, 81(12), 1998, pp. 2326-2331
Risultati: 1-14 |